Raxlaprazine etomoxil
Raxlaprazine etomoxil is a small molecule compound with dopamine D2 and D3 receptor modulating activity, which has potential application value in research related to mental illnesses. Raxlaprazine etomoxil exhibits high affinity for human recombinant D2L receptors, with an inhibition constant (Ki) of 1.95 nM. Raxlaprazine etomoxil effectively inhibits forskolin-stimulated cAMP accumulation, with an half maximal effective concentration (EC50) of 3.72 nM in functional activity experiments[1].
Product Specifications
CAS Number
3034857-88-7
UNSPSC
12352005
Target
Dopamine Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
ClC1=C(C=CC=C1Cl)N2CCN(CC2)CC[C@H]3CC[C@@H](CC3)NC(N(C)COCC)=O
Molecular Formula
C23H36Cl2N4O2
Molecular Weight
471.46
References & Citations
[1]István BORZA, et al. Dopamine d3/d2 receptor modulating compounds. French. WO2024150068A2
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Phosphatidylethanolamine Antibody (IgM) Elisa Kit
Atp5s sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)